Study of Bencycloquidium Bromide Nasal Spray in the Treatment of Moderate-severe Persistent Allergic Rhinitis
Clinical trial NCT05038202 · UNKNOWN
Trial details
- NCT number
- NCT05038202
- Sponsor
- Yingu Pharmaceutical Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-16
- Primary completion
- 2024-04-30
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.